Patent intelligence · US
US 11925686
Materials for phototherapies of ophthalmic diseases
Materials for phototherapies of ophthalmic diseases
Patent details — US 11925686
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 12, 2024
- Expiration
- Mar 7, 2044
- Claims
- 7
- CPC classes
- A61K, A61K41/0057, A61K41/0071, A61K41/0076
Quick answer
US 11925686 (Materials for phototherapies of ophthalmic diseases) is held by EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.. Status: granted. Granted Mar 12, 2024. Expires Mar 7, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 7
- CPC classes
- A61K, A61K41/0057, A61K41/0071, A61K41/0076, A61K47/58, A61K47/6957
More from EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Related pharmaceutical patents in our USPTO index.
-
US 12383631
Immune antigen specific IL-18 immunocytokines and uses thereof
granted -
US 12350120
Gum-protecting and teeth-whitening strip and preparation method thereof
granted -
US 12220447
Proteolytic enzyme composition
granted -
US 12215133
GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and use
granted -
US 12173062
Modified TNF-α antibodies and uses thereof
granted -
US 12115136
Fortified CBD oil for treatment of PTSD
granted -
US 12097230
Method and composition for treating post operative conditions
granted
Frequently asked questions
What is US patent 11925686?
US 11925686 (Materials for phototherapies of ophthalmic diseases) is held by EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.. Status: granted. Granted Mar 12, 2024. Expires Mar 7, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11925686?
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 57 pharmaceutical patents for this assignee.
When does US 11925686 expire?
Our index shows an expiration date of Mar 7, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.